Published on Sep 8, 2016
Deltex Medical Group PLC (LON:DEMG) would not be the first British company to
find a more welcome reception in the USA than in its home, and it has
just announced that its US sales have overtaken those from the UK for
the first time.
Chief executive officer Ewan Philips tells Proactive Investors that the company now has 27 “platform accounts” in the USA, which will form a bridgehead for its US sales initiatives. Sadly, back in Blighty, despite masses of evidence pointing to the superiority of its oesophageal Doppler monitoring technology (ODM) and a recommendation that it should be taken up by UK hospitals, inertia rules the day. Philips says the company has reverted to its old sales policy of “knocking on surgery doors” to persuade surgeons of the benefits of ODM.
http://www.4-traders.com/DELTEX-MEDICAL-GROUP-PLC-4002474/
No comments:
Post a Comment